The prevalence of factor V G1691A but not of prothrombin G20210A and methylenetetrahydrofolate reductase C677T is remarkably low in French Basques [9]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 2, 2004, Pages 361-362

  Bauduer, Frédéric ^a   Zivelin, A ^b   Ducout, L ^a   Shpringer, E ^b   Seligsohn, U ^b  

^a CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

CONFIDENCE INTERVAL; ETHNIC GROUP; FEMALE; FRANCE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HOMOZYGOSITY; HOSPITAL ADMISSION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; SPAIN; GENETICS; POINT MUTATION; PREVALENCE; THROMBOPHILIA;

FACTOR V; FEMALE; FRANCE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POINT MUTATION; PREVALENCE; PROTHROMBIN; THROMBOPHILIA;

EID: 4644227898     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7933.2004.0584i.x     Document Type: Letter

References (13)

1. Cavalli-Sforza LL, Menozzi P, Piazza A. The History and Geography of Human Genes. Princeton, NJ: Princeton University Press, 1994.
2. Salomon O, Steinberg M, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arteroscler Thromb Vasc Biol 1999; 19: 511-8.
3. Rees DC. The population genetics of factor V Leiden (Arg506Gln). Br J Haematol 1996; 95: 579-86.
4. Zabalegui N, Montes R, Orbe J, Ayape ML, Medarde A, Paramo JA, Rocha E. Prevalence of FVR506Q and prothrombin 20210A mutations in the Navarrese population. Thromb Haemost 1998; 80: 522-3 [letter].
5. Soria JM, Baiget M, Castano L, Tejada MI, Peretz-Nanclares G. Genetic risk factors for thrombosis in a Basque population and their possible contribution to the analysis of a complex disease such as thrombophilia. Haematologica 2001; 86: 889-90 [letter].
6. Lucotte G, Mercier G. Frequency of factor V Leiden (Arg506Gln) in France. Br J Haematol 1997; 99: 237-41.
7. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.
8. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a huge review. Am J Epidemiol 2000; 151: 862-77.
9. Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner B, Eldor A, Seligsohn U. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997; 89: 397-402.
10. Zivelin A, Rosenberg N, Faier S, Kornblot N, Peretz H, Mannhalter C, Horellou MH, Seligsohn U. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998; 92: 1119-24.
11. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E, Seligsohn U. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 2002; 70: 758-62.
12. De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 1998; 24: 367-77.
13. Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: the European burden. Br J Haematol 1999; 105: 564-6.